CHEMCOM
ActiveSummary
The computed 12-month bankruptcy probability of CHEMCOM is 2.4% (moderate). The 2025 annual accounts show negative equity (-€36,451) and a net result of -€75,173. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 5% of 316 sector peers (NACE 20, financial year 2025). The company has been active since 2000 and the Belgian Official Gazette contains no insolvency or warning signals.
Directors
Directors
8 directors, no change since 2026
Board 8
Marc PARMENTIER
CurrentDirector · since 26-05-2006
Gäetan Waucquez
CurrentDirector · since 28-05-2010
COVORIM
CurrentDirector · since 03-06-2019 · Private limited company · permanent representative: Benedikt Van der Vorst
HEXAGON ADVISORY SRL
CurrentDirector · since 11-10-2021 · Legal entity · permanent representative: Thibaut Hofman
Gilbert Vassart
CurrentDirector · since 28-06-2023
A.M.I.R.
CurrentDirector · since 31-05-2024 · Legal entity · permanent representative: Gilbert Vassart
Joëlle Dumont
CurrentDirector · since 29-06-2026
Nathalie Delwart
CurrentDirector · since 29-06-2026
2 not recently confirmed
Still in office according to the deeds, but no deed of the last six years confirms the mandate. Mandates like this have often ended since, in a deed we have not read yet.
Biotec sa
Not recently confirmedDirector · since 26-05-2006 · Legal entity · permanent representative: Jean-Marie Delwart
EUROSCREEN
Not recently confirmedDirector · since 30-05-2008 · Legal entity
Permanent representatives 3
Benedikt Van der Vorst
CurrentPermanent representative · since 03-06-2019 · for COVORIM
Thibaut Hofman
CurrentPermanent representative · since 11-10-2021 · for HEXAGON ADVISORY SRL
Gilbert Vassart
CurrentPermanent representative · since 31-05-2024 · for A.M.I.R.
2 not recently confirmed
Still in office according to the deeds, but no deed of the last six years confirms the mandate. Mandates like this have often ended since, in a deed we have not read yet.
Jean-Marie Delwart
Not recently confirmedPermanent representative · since 26-05-2006 · for Biotec sa
Laurent Puissant Baeyens
Not recently confirmedReprésentant de metrobel s.a. · since 30-05-2008
Statutory auditor 1
Ernst et Young Reviseurs d'Entreprises
CurrentStatutory auditor · since 31-05-2024 · permanent representative: Carlo-Sébastien D'Addario
Derived from published Gazette deeds. The KBO keeps the official list of office holders; we do not read it, so the two can differ.
See the directors and other office holders in the KBO →
Mandate history
23 people since 2006, 12 in office
- Board
- Permanent representative
- Statutory auditor
- not recently confirmed
- began earlier
| Name | Functions and periods |
|---|---|
| Marc PARMENTIER |
|
| Gäetan Waucquez |
|
| Nathalie Delwart |
|
| COVORIM |
|
| HEXAGON ADVISORY SRL |
|
| Gilbert Vassart |
|
| A.M.I.R. |
|
| Joëlle Dumont |
|
| Ernst et Young Reviseurs d'Entreprises |
|
| Biotec sa |
|
| EUROSCREEN |
|
| Laurent Puissant Baeyens |
|
| Charles Delwart |
|
| CONTHEGAS CONSULTING |
|
| RSM Reviseurs d'Entreprises-Bedrijfsrevisoren |
|
| Jacques Dumont |
|
| Jean-Marie Delwart |
|
| FLORINVEST |
|
| Mazars SC scrl |
|
| Compagnie Du Bois Sauvage |
|
| SCPRL Chartes de Streel |
|
| Alexandre Schmitz |
|
| Guy Paquot |
|
Owners and capital
Owners
5 ownersChain of control
- FLORIDIENNE SA
- CHEMCOM
Highest known parent: FLORIDIENNE SA. The sources do not say who stands above it.
Owners 5
- FLORIDIENNE SAconsolidating parentconsolidates
- Sourceaccounts Natix 202541.59%
-
20.31%
-
3.57%
-
1.73%
According to the 2025 annual accounts of CHEMCOM and those of the other companies, the acts in the Belgian Official Gazette and the LEI register. Annual accounts state the shareholders that notified the company under article 7:225 of the Code of Companies and Associations and the parent companies that consolidate it. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not include these statements in its annual accounts, or does not have to, is not listed.
Capital and shareholders
Capital over the years
- 03-04-2023 Capital increase of €499,974.63 · to €3,196,634.63 · 17,975 new shares
- 20-05-2022 Capital increase of €500,002.44 · to €4,328,951.71 · 8,988 new shares · “apport de diverses créances – avances d'actionnaires”
- 20-05-2022 Capital increase of €2,012,364.64 · to €6,341,316.35 · no new shares · from reserves
- 20-05-2022 Capital reduction of €3,644,656.35 · to €2,696,660 · to absorb losses
- 05-02-2021 Capital increase of €1,159,996.76 · to €3,828,949.27 · 20,852 new shares
- 18-08-2020 Capital increase of €399,979.70 · to €2,668,952.51 · 7,190 new shares
- 17-09-2018 Capital increase of €1,600,141.32 · to €1,687,861.83 · 28,764 new shares · in cash
- 17-09-2018 Capital increase of €581,110.98 · to €2,268,972.81 · 10,446 new shares · in kind
Show 3 older capital entries
- 21-01-2016 Capital reduction of €4,400,000 · to €87,720.51 · to absorb losses
- 08-01-2015 Capital increase of €1,000,060.51 · to €4,487,720.51 · 17,977 new shares
- 18-10-2011 Capital increase of €179,760 · to €3,487,660 · 8,988 new shares